NO166409C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.Info
- Publication number
- NO166409C NO166409C NO862487A NO862487A NO166409C NO 166409 C NO166409 C NO 166409C NO 862487 A NO862487 A NO 862487A NO 862487 A NO862487 A NO 862487A NO 166409 C NO166409 C NO 166409C
- Authority
- NO
- Norway
- Prior art keywords
- branched
- straight
- alkyl
- optionally substituted
- different
- Prior art date
Links
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical class C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- -1 1,4-butylene Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cephalosporin Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21236/85A IT1222367B (it) | 1985-06-21 | 1985-06-21 | Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO862487D0 NO862487D0 (no) | 1986-06-20 |
| NO862487L NO862487L (no) | 1986-12-22 |
| NO166409B NO166409B (no) | 1991-04-08 |
| NO166409C true NO166409C (no) | 1991-07-24 |
Family
ID=11178826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862487A NO166409C (no) | 1985-06-21 | 1986-06-20 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4703054A (no) |
| EP (1) | EP0207680B1 (no) |
| JP (1) | JPH0688979B2 (no) |
| KR (1) | KR870000305A (no) |
| AT (1) | ATE56020T1 (no) |
| AU (1) | AU590283B2 (no) |
| CA (1) | CA1273450A (no) |
| DE (1) | DE3673709D1 (no) |
| DK (1) | DK290386A (no) |
| FI (1) | FI862422A7 (no) |
| GR (1) | GR861578B (no) |
| HU (1) | HUT41741A (no) |
| IL (1) | IL79138A (no) |
| IT (1) | IT1222367B (no) |
| NO (1) | NO166409C (no) |
| NZ (1) | NZ216552A (no) |
| PH (2) | PH23229A (no) |
| ZA (1) | ZA864446B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209644B (it) * | 1985-06-21 | 1989-08-30 | Isf Spa | Composti farmacologicamente attivi. |
| FR2677984B1 (fr) * | 1991-06-21 | 1994-02-25 | Elf Sanofi | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
| JP2606026B2 (ja) * | 1991-07-09 | 1997-04-30 | コクヨ株式会社 | フォルダー |
| RU2142470C1 (ru) * | 1998-12-22 | 1999-12-10 | Анохина Ирина Петровна | Тетрапептид trp-nle-asp-phenh-ch(ch3)2, обладающий антиалкогольной активностью |
| EP1263735B1 (en) * | 2000-01-18 | 2007-07-04 | The Regents of The University of California | Acid addition salts of imidazolidinones as reaction catalysts |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH470396A (de) * | 1963-08-12 | 1969-03-31 | Hoffmann La Roche | Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen |
| IT1209644B (it) * | 1985-06-21 | 1989-08-30 | Isf Spa | Composti farmacologicamente attivi. |
-
1985
- 1985-06-21 IT IT21236/85A patent/IT1222367B/it active
-
1986
- 1986-06-06 FI FI862422A patent/FI862422A7/fi not_active Application Discontinuation
- 1986-06-13 ZA ZA864446A patent/ZA864446B/xx unknown
- 1986-06-16 NZ NZ216552A patent/NZ216552A/xx unknown
- 1986-06-17 EP EP86304650A patent/EP0207680B1/en not_active Expired - Lifetime
- 1986-06-17 AT AT86304650T patent/ATE56020T1/de not_active IP Right Cessation
- 1986-06-17 IL IL79138A patent/IL79138A/xx unknown
- 1986-06-17 DE DE8686304650T patent/DE3673709D1/de not_active Expired - Lifetime
- 1986-06-18 GR GR861578A patent/GR861578B/el unknown
- 1986-06-20 PH PH33924A patent/PH23229A/en unknown
- 1986-06-20 JP JP61144688A patent/JPH0688979B2/ja not_active Expired - Lifetime
- 1986-06-20 KR KR1019860004922A patent/KR870000305A/ko not_active Ceased
- 1986-06-20 NO NO862487A patent/NO166409C/no unknown
- 1986-06-20 HU HU862610A patent/HUT41741A/hu unknown
- 1986-06-20 US US06/876,946 patent/US4703054A/en not_active Expired - Lifetime
- 1986-06-20 CA CA000512111A patent/CA1273450A/en not_active Expired - Fee Related
- 1986-06-20 DK DK290386A patent/DK290386A/da not_active Application Discontinuation
- 1986-06-20 AU AU58917/86A patent/AU590283B2/en not_active Ceased
-
1987
- 1987-08-20 PH PH35708A patent/PH24336A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR861578B (en) | 1986-10-21 |
| DK290386D0 (da) | 1986-06-20 |
| EP0207680A3 (en) | 1989-01-18 |
| IT1222367B (it) | 1990-09-05 |
| NZ216552A (en) | 1989-11-28 |
| FI862422A0 (fi) | 1986-06-06 |
| ZA864446B (en) | 1987-03-25 |
| DE3673709D1 (de) | 1990-10-04 |
| NO166409B (no) | 1991-04-08 |
| JPH0688979B2 (ja) | 1994-11-09 |
| NO862487L (no) | 1986-12-22 |
| KR870000305A (ko) | 1987-02-17 |
| AU590283B2 (en) | 1989-11-02 |
| PH23229A (en) | 1989-06-06 |
| FI862422A7 (fi) | 1986-12-22 |
| EP0207680B1 (en) | 1990-08-29 |
| ATE56020T1 (de) | 1990-09-15 |
| AU5891786A (en) | 1986-12-24 |
| CA1273450A (en) | 1990-08-28 |
| IL79138A (en) | 1991-04-15 |
| PH24336A (en) | 1990-06-13 |
| IT8521236A0 (it) | 1985-06-21 |
| US4703054A (en) | 1987-10-27 |
| JPS6230763A (ja) | 1987-02-09 |
| EP0207680A2 (en) | 1987-01-07 |
| DK290386A (da) | 1987-02-11 |
| NO862487D0 (no) | 1986-06-20 |
| HUT41741A (en) | 1987-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL74631A (en) | 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them | |
| NO168173C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater | |
| NO166409C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. | |
| NO168428C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat |